BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ovarian cancer. It also develops BA3021, a CAB ADC for multiple solid tumor types, including NSCLC, melanoma, and ovarian cancer; and BA3071, which is a CAB anti-cytotoxic T-lymphocyte-associated antigen 4 antibody for renal cell carcinoma, NSCLC, small cell lung cancer, hepatocellular carcinoma, melanoma, bladder cancer, gastric cancer, and cervical cancer. BioAtla, Inc. was founded in 2007 and is based in San Diego, California.
Over the last 12 months, insiders at BioAtla, Inc. have bought $0 and sold $0 worth of BioAtla, Inc. stock.
On average, over the past 5 years, insiders at BioAtla, Inc. have bought $26.51M and sold $101.07M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 4,000 shares for transaction amount of $9,320 was made by MCBRINN SYLVIA (director) on 2023‑12‑26.
2023-12-26 | director | 4,000 0.0082% | $2.33 | $9,320 | -13.87% | |||
2023-12-20 | Chief Executive Officer | 50,000 0.1107% | $2.14 | $106,910 | +1.47% | |||
2023-12-19 | See Remarks | 7,495 0.0159% | $2.04 | $15,262 | +3.04% | |||
2023-12-19 | director | 20,000 0.0427% | $2.05 | $41,048 | +3.04% | |||
2023-09-08 | director | 2,000 0.0044% | $2.54 | $5,080 | -17.05% | |||
2023-03-29 | Chief Executive Officer | 40,800 0.0845% | $2.47 | $100,862 | +1.79% | |||
2023-03-28 | See Remarks | 20,000 0.0429% | $2.40 | $47,970 | +8.51% | |||
2023-03-28 | director | 4,000 0.0084% | $2.35 | $9,400 | +8.51% | |||
2022-12-19 | director | 3,700 0.0097% | $8.33 | $30,813 | -64.47% | |||
2022-11-22 | director | 2,000 0.0048% | $8.27 | $16,540 | -66.02% | |||
2022-08-12 | Chief Executive Officer | 26,350 0.0788% | $7.84 | $206,600 | -46.78% | |||
2022-06-21 | Chief Executive Officer | 40,308 0.114% | $2.91 | $117,296 | +40.73% | |||
2022-06-07 | See Remarks | 10,000 0.0258% | $2.97 | $29,720 | +25.65% | |||
2021-12-02 | Sale | Chief Executive Officer | 4,811 0.0135% | $21.76 | $104,666 | -70.68% | ||
2021-12-02 | Sale | President | 2,984 0.0084% | $21.76 | $64,918 | -70.68% | ||
2021-12-02 | Sale | Chief Financial Officer | 1,434 0.004% | $21.76 | $31,198 | -70.68% | ||
2021-12-02 | Sale | Chief Medical Officer | 820 0.0023% | $21.76 | $17,839 | -70.68% | ||
2021-12-02 | Sale | See Remarks | 200 0.0006% | $21.76 | $4,351 | -70.68% | ||
2021-12-01 | Sale | Chief Executive Officer | 24,321 0.0763% | $23.03 | $560,226 | -69.08% | ||
2021-12-01 | Sale | President | 628 0.002% | $23.03 | $14,466 | -69.08% |
Cormorant Asset Management, LP | 2292060 3.9501% | $0.54 | 1 | 0 | +17.46% | |
SHORT JAY M PHD | Chief Executive Officer | 1439283 2.4805% | $0.54 | 4 | 13 | <0.0001% |
Smith Scott Andrew | President | 345656 0.5957% | $0.54 | 0 | 9 | |
Levy Guy | director | 217358 0.3746% | $0.54 | 1 | 2 | +17.46% |
WALDRON RICHARD A | Chief Financial Officer | 134469 0.2317% | $0.54 | 0 | 7 | |
Vasquez Christian | See Remarks | 115659 0.1993% | $0.54 | 3 | 7 | +17.08% |
Sievers Eric | Chief Medical Officer | 91506 0.1577% | $0.54 | 0 | 9 | |
STEINMAN LAWRENCE | director | 38459 0.0663% | $0.54 | 1 | 4 | |
MCBRINN SYLVIA | director | 15125 0.0261% | $0.54 | 5 | 0 | <0.0001% |
Soleus Capital Management, L.P. | $13.98M | 8.45 | 4.07M | 0% | +$0 | 0.06 | |
BlackRock | $9.56M | 5.78 | 2.78M | -3.62% | -$358,836.70 | <0.0001 | |
The Vanguard Group | $7.22M | 4.36 | 2.1M | +0.85% | +$60,774.48 | <0.0001 | |
Morgan Stanley | $6.57M | 3.97 | 1.91M | -0.15% | -$10,220.24 | <0.0001 | |
Tang Capital Management, LLC | $5.07M | 3.06 | 1.47M | -41.6% | -$3.61M | 0.02 | |
Deutsche Bank | $4.28M | 2.59 | 1.24M | +10.58% | +$409,511.39 | <0.01 | |
Cormorant Asset Management Lp | $4.03M | 2.43 | 1.17M | -0.87% | -$35,242.80 | 0.19 | |
Renaissance Technologies | $3.43M | 2.07 | 996,300 | +0.89% | +$30,269.60 | 0.01 | |
Geode Capital Management | $3.18M | 1.92 | 922,938 | +2.09% | +$64,878.64 | <0.0001 | |
Millennium Management LLC | $3.01M | 1.82 | 873,654 | +299.29% | +$2.25M | <0.01 | |
State Street | $2.72M | 1.65 | 791,278 | +9.24% | +$230,166.93 | <0.0001 | |
Boxer Capital, LLC | $2.36M | 1.43 | 686,347 | 0% | +$0 | 0.05 | |
Massachusetts Financial Services Co Ma | $1.81M | 1.09 | 526,462 | -0.51% | -$9,267.36 | <0.01 | |
Healthcare Of Ontario Pension Plan Trust Fund | $1.76M | 1.07 | 512,300 | 0% | +$0 | 0.01 | |
Northern Trust | $1.22M | 0.74 | 353,940 | -0.55% | -$6,721.76 | <0.0001 | |
MAI Capital Management, LLC | $1.14M | 0.69 | 330,395 | New | +$1.14M | 0.01 | |
Two Sigma Advisers LP | $1.03M | 0.62 | 299,700 | +14.87% | +$133,472.00 | <0.01 | |
Bank of Montreal | $907,156.00 | 0.54 | 260,677 | -13.29% | -$139,001.65 | <0.0001 | |
Dimensional Fund Advisors | $895,294.00 | 0.54 | 260,260 | +23.49% | +$170,286.80 | <0.0001 | |
Connor Clark & Lunn Investment Management Ltd | $804,743.00 | 0.49 | 233,937 | +74.36% | +$343,212.12 | <0.01 | |
Ubs Oconnor Llc | $721,609.00 | 0.44 | 209,770 | +16.27% | +$100,953.71 | 0.03 | |
Two Sigma | $698,626.00 | 0.42 | 203,089 | +18.85% | +$110,826.46 | <0.01 | |
Myda Advisors Llc | $619,200.00 | 0.37 | 180,000 | -18.18% | -$137,600.00 | 0.12 | |
Nuveen | $611,811.00 | 0.37 | 177,852 | 0% | +$0 | <0.0001 | |
Xtx Topco Ltd | $565,422.00 | 0.34 | 164,367 | New | +$565,422.00 | 0.01 | |
Acadian Asset Management | $532,000.00 | 0.32 | 155,188 | +57.65% | +$194,537.83 | <0.01 | |
Toroso Investments Llc | $502,302.00 | 0.3 | 145,174 | -5.88% | -$31,389.12 | <0.01 | |
Formidable Asset Management LLC | $499,399.00 | 0.3 | 145,174 | -5.88% | -$31,207.71 | 0.09 | |
Woodline Partners LP | $458,256.00 | 0.28 | 133,214 | New | +$458,256.00 | <0.01 | |
BNY Mellon | $421,455.00 | 0.26 | 122,516 | -7.88% | -$36,078.72 | <0.0001 | |
Charles Schwab | $411,249.00 | 0.25 | 119,549 | 0% | +$0 | <0.0001 | |
Bridgeway Capital Management | $309,600.00 | 0.19 | 90,000 | -10% | -$34,400.00 | <0.01 | |
Susquehanna International Group | $306,790.00 | 0.19 | 89,183 | +50.32% | +$102,697.92 | <0.0001 | |
Panagora | $306,408.00 | 0.19 | 89,072 | -20.02% | -$76,691.44 | <0.01 | |
Chase Investment Counsel Corp | $263,000.00 | 0.16 | 76,742 | New | +$263,000.00 | 0.1 | |
Manatuck Hill Partners LLC | $258,000.00 | 0.16 | 75,000 | New | +$258,000.00 | 0.05 | |
Citadel Advisors LLC | $249,871.00 | 0.15 | 72,637 | -0.69% | -$1,747.52 | <0.0001 | |
Sc H Financial Advisors Inc | $225,385.00 | 0.14 | 65,519 | 0% | +$0 | 0.1 | |
RhumbLine Advisers | $216,005.00 | 0.13 | 62,795 | +3.47% | +$7,251.19 | <0.0001 | |
Cornercap Investment Counsel Inc | $210,528.00 | 0.13 | 61,200 | 0% | +$0 | 0.03 | |
Goldman Sachs | $162,313.00 | 0.1 | 47,184 | +21.76% | +$29,009.53 | <0.0001 | |
UBS | $162,805.00 | 0.1 | 47,327 | -0.97% | -$1,596.16 | <0.0001 | |
Simplex Trading Llc | $148,000.00 | 0.09 | 43,239 | +262.56% | +$107,179.26 | <0.01 | |
American Century Investments | $109,695.00 | 0.07 | 31,888 | New | +$109,695.00 | <0.0001 | |
Kennedy Capital Management Inc | $108,044.00 | 0.07 | 31,408 | +6.39% | +$6,487.87 | <0.01 | |
Barclays | $107,000.00 | 0.07 | 31,202 | -48.76% | -$101,818.38 | <0.0001 | |
JPMorgan Chase | $105,136.00 | 0.06 | 30,563 | -21.59% | -$28,954.28 | <0.0001 | |
Virtu Financial Llc | $103,000.00 | 0.06 | 30,012 | New | +$103,000.00 | 0.01 | |
New York State Common Retirement Fund | $94,000.00 | 0.06 | 27,260 | -0.16% | -$148.28 | <0.0001 | |
American International Group | $74,989.00 | 0.05 | 21,799 | -0.85% | -$643.28 | <0.0001 |